Results

Total Results: 2,658 records

Showing results for "assess".

81. Lower Limb Prostheses: Measurement Instruments, Comparison of Component Effects by Subgroups, and Long-Term Outcomes | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/prosthesis/research
    September 06, 2018 - Purpose of Review To assess validity of instruments used in adult lower limb amputees, whether patient … of people with LLPs is needed to inform optimal matching of prosthetic components to patients and to assess

82. Treatment of Osteoarthritis of the Knee: An Update | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/osteoarthritis-knee-update/research-protocol
    June 16, 2016 - A number of assessment tools are used to assess clinical outcomes of treatment such as pain, quality … However, one commenter suggested trying to assess outcomes according to the localization of disease, … Evid Rep Technol Assess (Full Rep). 2007 Sep(157):1-157. PMID: 18088162. … PEDro or Cochrane to Assess the Quality of Clinical Trials? A Meta-Epidemiological Study. … ROBIS: A new tool to assess risk of bias in systematic reviews was developed.

83. Treatment of Osteoarthritis of the Knee: An Update (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoarthritis-knee-update_research-protocol.pdf
    June 15, 2016 - A number of assessment tools are used to assess clinical outcomes of treatment such as pain, quality … However, one commenter suggested trying to assess outcomes according to the localization of disease, … Evid Rep Technol Assess (Full Rep). 2007 Sep(157):1-157. PMID: 18088162. 2. … PEDro or Cochrane to Assess the Quality of Clinical Trials? A Meta- Epidemiological Study. … ROBIS: A new tool to assess risk of bias in systematic reviews was developed.

84. Real World Effectiveness of Carotid Artery Stenting (CAS) in Medicare Patients | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/coronary-stents-effectiveness/abstract
    April 14, 2010 - Aim 4: Assess if the effectiveness of CAS versus CEA differ among subgroups. … Aim 5: Assess the impact of unmeasured confounding in a well-designed comparative effectiveness study

85. Use of Natriuretic Peptide Measurement in the Management of Heart Failure | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/heart-failure-natriuretic-peptide/research
    November 20, 2013 - Structured Abstract Objectives To assess the diagnostic accuracy of B-type natriuretic peptide (BNP … whether treatment guided by BNP or NT-proBNP improves outcomes in HF compared with usual care To assess

86. Treatment for Bipolar Disorder in Adults: A Systematic Review | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/bipolar-disorder-treatment/final-report-2018
    August 07, 2018 - Purpose of Review To assess the effectiveness of drug and nondrug therapies for treating acute mania … Assess the effect of drug and nondrug interventions for treating acute symptoms associated with bipolar

87. Table 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-indicators-symposium_research.pdf
    April 01, 2010 - The next step should assess the quality of the conversations. … the conversations, and incorporating questions into the conversation for patients and families that assess … Another goal would aim to develop indicators that assess the infrastructure and resources needed for … Care teams must assess symptoms as a first step, followed by reassessment. … whether care teams provide quality psychosocial care • Assess training of providers; • Standardized

88. 8 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_chou_assessing_harms_when_comparing.pdf
    November 01, 2008 - Do not assume studies adequately assess harms because methods used to assess and report benefits are … Such information has several potentially valuable uses: To assess the number of unpublished trials … Observational Studies Observational studies are almost always necessary to assess harms adequately … In addition, caution should be used when considering use of summary scores to assess risk of bias. … Do not assume studies adequately assess harms because methods used to assess and report benefits are

89. 8 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-harms_methods.pdf
    November 01, 2008 - Do not assume studies adequately assess harms because methods used to assess and report benefits are … Such information has several potentially valuable uses: To assess the number of unpublished trials … Observational Studies Observational studies are almost always necessary to assess harms adequately … In addition, caution should be used when considering use of summary scores to assess risk of bias. … Do not assume studies adequately assess harms because methods used to assess and report benefits are

90. Dementia-Agitation-Aggression Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/dementia-agitation-aggression_research-protocol.pdf
    November 13, 2014 - We will use data provided by the systematic review to assess strength of evidence for results without … Two investigators will independently assess risk of bias for all included studies. … We will assess harms as dichotomous variables to acknowledge the inherent difficulties of assessing … There are various ways to assess harms; each has problems. … We will assess strength of evidence for key final health outcomes measured with validated scales.

91. Evidence-based Practice Center Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-surveillance_research-protocol.pdf
    May 19, 2011 - Men with clinically localized prostate cancer (T1–T2), without (or unable to assess) either regional … Based on the final inclusion and exclusion criteria, we will assess the titles and/or abstracts of … We will assess the directness (direct or indirect) of the evidence. … We will assess the precision (precise or imprecise) of the evidence based on the degree of certainty … Assessing Applicability We will qualitatively assess the applicability of included studies to the

92. Newer Medications for Lower Urinary Tract Symptoms (LUTS) Associated with Benign Prostatic Hyperplasia (BPH) | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/prostatic-hyperplasia-medications/research-protocol
    April 24, 2015 - There are two validated and widely used, nearly identical instruments used to assess LUTS, the American … Our review will comprehensively assess newer medications for LUTS/BPH newly used in the last 10 years … Information from grey literature will also be used to assess publication and reporting bias and inform … We will assess the clinical and methodological heterogeneity and variation in effect size to determine … We will assess strength of evidence for key final health outcomes measured with validated scales.

93. Slide 1
    effectivehealthcare.ahrq.gov/sites/default/files/sensitivity-analysis-chapter-11.pptx
    January 01, 2013 - Include several different comparison groups to assess robustness of the results. … Change the exposure, outcome, and covariate definitions to assess how well confounding is addressed in … Another option that can be used, when the data permit it, is an instrumental variable analysis to assess … Sample Graphical Presentation (2 of 2) Plot to assess the strength of unmeasured confounding necessary … Assess expected impact of unmeasured confounders on key measures of association.

94. Medical Therapies for Children With Autism Spectrum Disorder—An Update (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/asd-medical-executive-170505.pdf
    May 01, 2017 - Purpose of Review To assess effectiveness and safety of medical interventions for children with autism … We categorized studies as “other” if we could not assess strength of evidence for interventions and … We considered SOE to be insufficient to assess effects. N-acetylcysteine. … Data were inadequate to assess effects on other outcomes (insufficient strength of evidence). … Few studies reported data to assess time to effect of interventions.

95. Findings of Bayesian Mixed Treatment Comparison Meta-Analyses: Comparison and Exploration Using Real-World Trial Data and Simulation | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/bayesian-mixed-treatment/research
    January 31, 2013 - One explored subgroup effects with a binary covariate to assess whether efficacy of SGAs differs between … The other explored a continuous covariate to assess whether treatment efficacy varies by disease duration

96. Computer-based Clinical Decision Support (CDS) Tools for Gene-based Tests Used in Breast Cancer | Effective Health Care Program
    effectivehealthcare.ahrq.gov/products/breast-cancer-genetic-tests
    December 02, 2010 - Research Report A Primary Care-Focused, Computer-based Clinical Decision Support Tool to Assess

97. Relationship Between Use of Quality Measures and Improved Outcomes in Serious Mental Illness | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/mental-illness-outcomes/technical-brief
    January 15, 2015 - Using QMs to assess the effect of programs designed to improve the mental health of SMI populations is … agreed-upon list of preferred relevant QMs for the SMI population, and the outcomes against which to assess

98. Effective Health Care Program
    effectivehealthcare.ahrq.gov/health-topics/medicaid-0
    December 07, 2009 - March 10, 2014 A Primary Care-Focused, Computer-based Clinical Decision Support Tool to Assess

99. Assessing the Quality of Individual Studies (ppt file)
    effectivehealthcare.ahrq.gov/sites/default/files/assessing-quality.ppt
    January 01, 2010 - Health Technol Assess 2003;7(27):iii-x, 1-173. … Health Technol Assess 2004;8(25):iii, 1-234. … criterion Adjudicate differences between raters in a transparent manner when two raters independently assess … Health Technol Assess 2003;7(27):iii-x,1-173. … Health Technol Assess 2004;8(25):iii, 1-234.

100. Translation of a C. difficile Treatment Clinical Pathway Into Machine-Readable Clinical Decision Support Artifacts Prototyped for Electronic Health Record Implementation (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-translation-c-diff-treatment-clinical-pathway.pdf
     November 01, 2019 - Moving forward, instruments to assess the quality of clinical pathways and CDS will be necessary to … Extract L2 Recommendation Statements, Classify, and Assess for CDS Inclusion Eligibility ........... … Assess Feasibility and Barriers for Conversion of L2 to L3 CDS Artifact Task 3. … Extract Data, Catalog, and Assess for CDS Inclusion Eligibility Task 2. … Assess Feasibility and Identify Barriers for Conversion to L3 CDS Artifact Task 3.